electroCore, Inc. (NASDAQ:ECOR) Short Interest Update

electroCore, Inc. (NASDAQ:ECOR - Get Free Report) saw a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 89,500 shares, a decline of 22.8% from the December 31st total of 115,900 shares. Based on an average trading volume of 124,900 shares, the short-interest ratio is currently 0.7 days. Approximately 1.7% of the company's shares are sold short.

Hedge Funds Weigh In On electroCore

Large investors have recently bought and sold shares of the stock. HighTower Advisors LLC purchased a new stake in electroCore during the third quarter worth approximately $255,000. Renaissance Technologies LLC boosted its position in electroCore by 3.4% during the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company's stock worth $442,000 after purchasing an additional 2,270 shares during the period. Geode Capital Management LLC increased its stake in electroCore by 10.3% during the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company's stock worth $458,000 after buying an additional 5,951 shares during the period. Finally, International Assets Investment Management LLC increased its stake in shares of electroCore by 689.1% in the third quarter. International Assets Investment Management LLC now owns 535,146 shares of the company's stock worth $3,864,000 after buying an additional 467,326 shares during the last quarter. Hedge funds and other institutional investors own 26.74% of the company's stock.

electroCore Stock Down 1.0 %

Shares of ECOR stock traded down $0.16 during trading hours on Thursday, hitting $15.42. 32,765 shares of the company were exchanged, compared to its average volume of 97,641. The firm has a fifty day moving average of $14.77 and a 200 day moving average of $10.17. electroCore has a 1 year low of $5.32 and a 1 year high of $18.67. The firm has a market cap of $100.99 million, a PE ratio of -8.45 and a beta of 0.50.

Analyst Upgrades and Downgrades

Separately, HC Wainwright lifted their price objective on electroCore from $22.00 to $25.00 and gave the company a "buy" rating in a research report on Wednesday, December 18th.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.